Market Closed -
Sao Paulo
01:37:52 27/04/2024 am IST
5-day change
1st Jan Change
14.61
BRL
+4.28%
+4.06%
-19.01%
Sales 2024 *
7.79B
1.52B
127B
Sales 2025 *
8.36B
1.63B
136B
Capitalization
7.96B
1.56B
130B
Net income 2024 *
637M
125M
10.38B
Net income 2025 *
795M
155M
12.96B
EV / Sales 2024 *
1.46
x
Net Debt
2024
*
3.44B
672M
56.04B
Net Debt
2025
*
2.67B
521M
43.46B
EV / Sales 2025 *
1.27
x P/E ratio 2024 *
12.7
x
P/E ratio 2025 *
10.2
x
Employees
27,300
Yield 2024 *
2.34%
Yield 2025 *
5.16%
Free-Float
43.97%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024
08/03
Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
08/03
CI
Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
07/03
CI
Fleury S.A Seeks Inorganic Growth
10/11
CI
Transcript : Fleury S.A., Q3 2023 Earnings Call, Nov 10, 2023
10/11
Fleury S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
09/11
CI
Fleury Seeks Inorganic Growth
04/23/04
CI
Transcript : Fleury S.A., Q2 2023 Earnings Call, Aug 04, 2023
04/23/04
Fleury S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
03/23/03
CI
Transcript : Fleury S.A., Q1 2023 Earnings Call, May 05, 2023
05/23/05
Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
04/23/04
CI
Fleury S.A. completed the acquisition of Instituto Hermes Pardini S.A. from Pardini family and others.
28/23/28
CI
Transcript : Fleury S.A., Q4 2022 Earnings Call, Mar 17, 2023
17/23/17
Fleury S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
17/23/17
CI
Transcript : Fleury S.A., Q3 2022 Earnings Call, Nov 04, 2022
04/22/04
More news
1 day +4.28%
1 week +4.06%
Current month -2.60%
1 month -3.50%
3 months -11.40%
6 months -3.37%
Current year -19.01%
More quotes
Managers
Title Age Since
Chief Executive Officer
54
01/01/01
Director of Finance/CFO
63
23/21/23
Chief Tech/Sci/R&D Officer
48
01/07/01
Members of the board
Title Age Since
Director/Board Member
72
-
Director/Board Member
78
09/13/09
Director/Board Member
57
30/21/30
More insiders
Date
Price
Change
Volume
26/24/26
14.61
-0.34%
2,941,300
25/24/25
14.66
+0.89%
1,734,000
24/24/24
14.53
-1.29%
3,007,400
23/24/23
14.72
+5.07%
11,137,400
22/24/22
14.01
-0.21%
3,185,300
Delayed Quote
Sao Paulo, April 27, 2024 at 01:37 am IST
More quotes
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
More about the company
Last Close Price
14.61
BRL
Average target price
19.9
BRL
Spread / Average Target
+36.21%
Consensus
1st Jan change
Capi.
-19.01% 1.55B -17.89% 8.25B +39.20% 3.58B -39.11% 2.46B -8.06% 2.46B -7.35% 2.38B -40.66% 1.21B +7.56% 1.11B -15.34% 1.03B -16.56% 878M
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1